Cargando…

Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership

AIMS: To describe processes and outcomes of a priority setting partnership to identify the ‘top 10 research priorities’ in Type 2 diabetes, involving people living with the condition, their carers, and healthcare professionals. METHODS: We followed the four‐step James Lind Alliance Priority Setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Finer, S., Robb, P., Cowan, K., Daly, A., Shah, K., Farmer, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032840/
https://www.ncbi.nlm.nih.gov/pubmed/29485717
http://dx.doi.org/10.1111/dme.13613
_version_ 1783337582866726912
author Finer, S.
Robb, P.
Cowan, K.
Daly, A.
Shah, K.
Farmer, A.
author_facet Finer, S.
Robb, P.
Cowan, K.
Daly, A.
Shah, K.
Farmer, A.
author_sort Finer, S.
collection PubMed
description AIMS: To describe processes and outcomes of a priority setting partnership to identify the ‘top 10 research priorities’ in Type 2 diabetes, involving people living with the condition, their carers, and healthcare professionals. METHODS: We followed the four‐step James Lind Alliance Priority Setting Partnership process which involved: gathering uncertainties using a questionnaire survey distributed to 70 000 people living with Type 2 diabetes and their carers, and healthcare professionals; organizing the uncertainties; interim priority setting by resampling of participants with a second survey; and final priority setting in an independent group of participants, using the nominal group technique. At each step the steering group closely monitored and guided the process. RESULTS: In the first survey, 8227 uncertainties were proposed by 2587 participants, of whom 18% were from black, Asian and minority ethnic groups. Uncertainties were formatted and collated into 114 indicative questions. A total of 1506 people contributed to a second survey, generating a shortlist of 24 questions equally weighted to the contributions of people living with diabetes and their carers and those of healthcare professionals. In the final step the ‘top 10 research priorities’ were selected, including questions on cure and reversal, risk identification and prevention, and self‐management approaches in Type 2 diabetes. CONCLUSION: Systematic and transparent methodology was used to identify research priorities in a large and genuine partnership of people with lived and professional experience of Type 2 diabetes. The top 10 questions represent consensus areas of research priority to guide future research, deliver responsive and strategic allocation of research resources, and improve the future health and well‐being of people living with, and at risk of, Type 2 diabetes.
format Online
Article
Text
id pubmed-6032840
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60328402018-07-12 Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership Finer, S. Robb, P. Cowan, K. Daly, A. Shah, K. Farmer, A. Diabet Med Research Articles AIMS: To describe processes and outcomes of a priority setting partnership to identify the ‘top 10 research priorities’ in Type 2 diabetes, involving people living with the condition, their carers, and healthcare professionals. METHODS: We followed the four‐step James Lind Alliance Priority Setting Partnership process which involved: gathering uncertainties using a questionnaire survey distributed to 70 000 people living with Type 2 diabetes and their carers, and healthcare professionals; organizing the uncertainties; interim priority setting by resampling of participants with a second survey; and final priority setting in an independent group of participants, using the nominal group technique. At each step the steering group closely monitored and guided the process. RESULTS: In the first survey, 8227 uncertainties were proposed by 2587 participants, of whom 18% were from black, Asian and minority ethnic groups. Uncertainties were formatted and collated into 114 indicative questions. A total of 1506 people contributed to a second survey, generating a shortlist of 24 questions equally weighted to the contributions of people living with diabetes and their carers and those of healthcare professionals. In the final step the ‘top 10 research priorities’ were selected, including questions on cure and reversal, risk identification and prevention, and self‐management approaches in Type 2 diabetes. CONCLUSION: Systematic and transparent methodology was used to identify research priorities in a large and genuine partnership of people with lived and professional experience of Type 2 diabetes. The top 10 questions represent consensus areas of research priority to guide future research, deliver responsive and strategic allocation of research resources, and improve the future health and well‐being of people living with, and at risk of, Type 2 diabetes. John Wiley and Sons Inc. 2018-03-15 2018-07 /pmc/articles/PMC6032840/ /pubmed/29485717 http://dx.doi.org/10.1111/dme.13613 Text en © 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Finer, S.
Robb, P.
Cowan, K.
Daly, A.
Shah, K.
Farmer, A.
Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership
title Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership
title_full Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership
title_fullStr Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership
title_full_unstemmed Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership
title_short Setting the top 10 research priorities to improve the health of people with Type 2 diabetes: a Diabetes UK–James Lind Alliance Priority Setting Partnership
title_sort setting the top 10 research priorities to improve the health of people with type 2 diabetes: a diabetes uk–james lind alliance priority setting partnership
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032840/
https://www.ncbi.nlm.nih.gov/pubmed/29485717
http://dx.doi.org/10.1111/dme.13613
work_keys_str_mv AT finers settingthetop10researchprioritiestoimprovethehealthofpeoplewithtype2diabetesadiabetesukjameslindallianceprioritysettingpartnership
AT robbp settingthetop10researchprioritiestoimprovethehealthofpeoplewithtype2diabetesadiabetesukjameslindallianceprioritysettingpartnership
AT cowank settingthetop10researchprioritiestoimprovethehealthofpeoplewithtype2diabetesadiabetesukjameslindallianceprioritysettingpartnership
AT dalya settingthetop10researchprioritiestoimprovethehealthofpeoplewithtype2diabetesadiabetesukjameslindallianceprioritysettingpartnership
AT shahk settingthetop10researchprioritiestoimprovethehealthofpeoplewithtype2diabetesadiabetesukjameslindallianceprioritysettingpartnership
AT farmera settingthetop10researchprioritiestoimprovethehealthofpeoplewithtype2diabetesadiabetesukjameslindallianceprioritysettingpartnership